Novadigm Therapeutics Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
Novadigm Therapeutics General Information
Description
Operators of an immunotherapeutic firm intended to protect people from fungal and bacterial diseases. The company develops preventative vaccines containing a recombinant form of the albicans agglutinin-like sequence 3 (Als3) surface protein, which facilitates adherence to and invasion of human endothelial cells to reduce the severity of disease caused by both fungal and bacterial pathogens, enabling healthcare professionals to make patients immune before being attacked by the disease.
Contact Information
Website
www.novadigm.netCorporate Office
- 1622A Beacon Street
- Suite 302
- Brookline, MA 02446
- United States
Corporate Office
- 1622A Beacon Street
- Suite 302
- Brookline, MA 02446
- United States
Novadigm Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Mar-2021 | Completed | Generating Revenue | |||
| 6. Grant | 02-Jun-2017 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 03-Oct-2013 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 20-Feb-2013 | Completed | Generating Revenue | |||
| 3. Grant | Completed | Generating Revenue | ||||
| 2. Grant | 31-Dec-2009 | $240K | $18.1M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 27-Jun-2008 | $18.1M | $18.1M | Completed | Generating Revenue |
Novadigm Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Novadigm Therapeutics Comparisons
Industry
Financing
Details
Novadigm Therapeutics Competitors (11)
One of Novadigm Therapeutics’s 11 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Merck & Co. | Corporation | Rahway, NJ |
Novadigm Therapeutics Patents
Novadigm Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3426287-A1 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Inactive | 09-Mar-2016 | ||
| EP-3426287-A4 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Inactive | 09-Mar-2016 | ||
| US-10857216-B2 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Active | 09-Mar-2016 | ||
| US-20190076512-A1 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Active | 09-Mar-2016 | ||
| WO-2017155949-A1 | Methods and kits for use in preventing and treating vulvovaginal candidiasis | Inactive | 09-Mar-2016 | A61K39/0002 |
Novadigm Therapeutics Signals
Novadigm Therapeutics FAQs
-
When was Novadigm Therapeutics founded?
Novadigm Therapeutics was founded in 2005.
-
Where is Novadigm Therapeutics headquartered?
Novadigm Therapeutics is headquartered in Brookline, MA.
-
What is the size of Novadigm Therapeutics?
Novadigm Therapeutics has 3 total employees.
-
What industry is Novadigm Therapeutics in?
Novadigm Therapeutics’s primary industry is Biotechnology.
-
Is Novadigm Therapeutics a private or public company?
Novadigm Therapeutics is a Private company.
-
What is Novadigm Therapeutics’s current revenue?
The current revenue for Novadigm Therapeutics is .
-
How much funding has Novadigm Therapeutics raised over time?
Novadigm Therapeutics has raised $52.7M.
-
Who are Novadigm Therapeutics’s competitors?
Ona Therapeutics, Volastra, Avalyn Pharma, Ability Pharma, and Merck & Co. are some of the 11 competitors of Novadigm Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process